康希诺：曼海欣适用人群年龄范围由此前的3周岁扩大至6 周岁

Core Viewpoint - The announcement from CanSino indicates an expansion of the age range for its ACYW135 meningococcal polysaccharide conjugate vaccine, which is expected to positively impact the company's performance [1] Group 1 - The age range for the vaccine has been expanded from "3 months to 3 years (47 months)" to "3 months to 6 years (83 months)" [1] - The vaccine is identified as a quadrivalent meningococcal conjugate vaccine product in China [1] - The expansion of the applicable age group is anticipated to have a positive effect on the company's financial results [1]